Previous studies have demonstrated the dynamic effects of NAT in breast cancer patients with infiltrating tumor lymphocytes, CD8 + cells and upregulation of immune stimulatory signatures associated with pathological complete response [45–47]. This evidence concerns the gene CD8A and breast carcinoma.